WASHINGTON — America’s mayors are drooling over President Biden’s new high-stakes research agency, ARPA-H.
They picture a futuristic office building transforming a city’s skyline. Inside it sits a cadre of best-in-class scientists, working feverishly to help local companies develop the next generation of biomedical breakthroughs, transforming the city’s economy along the way.
That pretty daydream has spurred cities and states as diverse as Chicago, Philadelphia, St. Louis, Cleveland, Massachusetts, Georgia, North Carolina, and Texas to launch elaborate campaigns aimed at making sure the new agency lands in their backyard.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect